From Biomarkers to Bedside: Translating IIM Classification into Targeted Treatment Strategies

Get a Free Consultation

In this case-based CME Outfitters recorded webcast, expert faculty will guide learners through real-world diagnostic and treatment decision points that translate biomarker-informed IIM classification into clinical practice, linking subtype recognition to further diagnostic evaluation, targeted comorbidity assessment, multidisciplinary care, and current and emerging steroid-sparing treatment strategies. Patient perspectives on function, treatment burden, quality of life, and personal goals will be integrated into these decisions, while investigational FcRn inhibition is considered within a fair and balanced therapeutic landscape.

Learn More Here